1. Home
  2. MLSS vs CLGN Comparison

MLSS vs CLGN Comparison

Compare MLSS & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MLSS

Milestone Scientific Inc.

HOLD

Current Price

$0.25

Market Cap

22.9M

Sector

Health Care

ML Signal

HOLD

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

HOLD

Current Price

$1.65

Market Cap

18.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLSS
CLGN
Founded
1989
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Specialties
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.9M
18.4M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
MLSS
CLGN
Price
$0.25
$1.65
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$1.00
$11.50
AVG Volume (30 Days)
297.3K
20.4K
Earning Date
11-13-2025
11-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,929,517.00
$2,475,000.00
Revenue This Year
$8.95
$1,596.12
Revenue Next Year
$7.51
$85.83
P/E Ratio
N/A
N/A
Revenue Growth
0.59
280.77
52 Week Low
$0.22
$1.30
52 Week High
$1.32
$4.98

Technical Indicators

Market Signals
Indicator
MLSS
CLGN
Relative Strength Index (RSI) 35.46 47.17
Support Level $0.26 $1.40
Resistance Level $0.30 $1.99
Average True Range (ATR) 0.03 0.16
MACD -0.00 0.01
Stochastic Oscillator 35.80 42.37

Price Performance

Historical Comparison
MLSS
CLGN

About MLSS Milestone Scientific Inc.

Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: